At the 2019 IAS Meeting, David T. Rubin, MD, highlighted current challenges in IBD management, the importance of proactive care, and treat to target strategies.
At the 2019 IAS Meeting, David T. Rubin, MD, highlighted current challenges in IBD management, the importance of proactive care, and treat to target strategies.
Therapeutic drug monitoring has the potential to optimize inflammatory bowel disease management. Siddharth Singh, MD, MS, answers our questions about this important topic in advance of his presentation at...
Therapeutic drug monitoring has the potential to optimize inflammatory bowel disease management. Siddharth Singh, MD, MS, answers our questions about this important topic in advance of his presentation at...
An estimated 3 million Americans are impacted by IBD, and complications often arise. Consultant360 recently spoke with Dr Alan Moss about the challenges with treating IBD and ways to overcome them.
An estimated 3 million Americans are impacted by IBD, and complications often arise. Consultant360 recently spoke with Dr Alan Moss about the challenges with treating IBD and ways to overcome them.
Bincy P. Abraham, MD, MS, answers our questions about the importance of therapeutic drug monitoring for patients with IBD, how the process has evolved over time, and how you can overcome the challenges...
The lead authors of new publication on the challenges associated with inflammatory bowel disease, obesity, aging, and other comorbidities, and the special considerations for women who are or wish to become...
The lead authors of new publication on the challenges associated with inflammatory bowel disease, obesity, aging, and other comorbidities, and the special considerations for women who are or wish to become...
